AVALO THERAPEUTICS INC (AVTX)
US05338F3064 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to AVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 35.7. This target is 111.24% above the current price.
AVTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AVTX.
In the previous month the buy percentage consensus was at a similar level.
AVTX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-16 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2023-06-27 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-06-27 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-05-10 | RBC Capital | Maintains | Outperform |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-03-03 | RBC Capital | Maintains | Outperform |
| 2022-03-03 | Jefferies | Downgrade | Buy -> Hold |
| 2021-09-24 | RBC Capital | Initiate | Outperform |